Effects of cipaglucosidase alfa-atga: A Synthesis of Findings from 13 Studies
- Home
- Effects of cipaglucosidase alfa-atga
This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effects of cipaglucosidase alfa-atga: A Synthesis of Findings from 13 Studies", please consult your doctor.
For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
Major Research Findings
Clozapine is an effective treatment for a portion of people with schizophrenia (SZ) who are resistant to the beneficial effects of other antipsychotic drugs. 13 , 4 , 9 , 10 , 7 , 3 , 5 , 6 , 11 , 2 , 1 , 12 , 8 However, a significant proportion of people taking clozapine experience persistent symptoms, even with adequate doses. This group is known as ‘clozapine-resistant’ and comprises 40-60% of patients. 13 Researchers are exploring potential agents that could be used alongside clozapine to enhance its effectiveness without increasing the burden of adverse effects. 13 N-Acetylcysteine (NAC) is one such candidate agent, showing promise in earlier pilot studies. 13 Clozapine is superior to haloperidol in treating both positive and negative symptoms in stable outpatients with schizophrenia. 4 Furthermore, clozapine demonstrates superior antidepressant effects compared to quetiapine and comparable effects to olanzapine and risperidone in chronic schizophrenia, regardless of the presence of a major depressive episode. 9 Despite its effectiveness, clozapine has been associated with potentially life-threatening side effects, including agranulocytosis and myocarditis. 8
Benefits and Risks
Benefit Summary
Clozapine is an effective treatment for a proportion of people with schizophrenia (SZ) who are resistant to the beneficial effects of other antipsychotic drugs. 13 , 4 , 9 , 10 , 7 , 3 , 5 , 6 , 11 , 2 , 1 , 12 , 8
Risk Summary
Clozapine can cause potentially life-threatening side effects, including agranulocytosis and myocarditis. 8 Up to 50% of patients develop fever and flu-like symptoms during the first month of treatment, likely due to increased cytokines. 8 The risk of side effects with a suspected immunological mechanism peaks during this initial period. 8 Patients experiencing fever during the first weeks of treatment should undergo thorough physical examination and testing to rule out infection, agranulocytosis, myocarditis, and neuroleptic malignant syndrome. 8
Comparison of Studies
Commonalities
Multiple studies have shown clozapine’s effectiveness in treating schizophrenia, particularly in patients resistant to other antipsychotics. 13 , 4 , 9 , 10 , 7 , 3 , 5 , 6 , 11 , 2 , 1 , 12 , 8
Differences
Research findings indicate that clozapine’s effectiveness and side effect profiles can vary among individuals. 13 , 4 , 9 , 10 , 7 , 3 , 5 , 6 , 11 , 2 , 1 , 12 , 8
Consistency and Discrepancies of Results
While clozapine shows promise in treating schizophrenia, individual responses can vary, requiring careful monitoring and personalized treatment approaches. 13 , 4 , 9 , 10 , 7 , 3 , 5 , 6 , 11 , 2 , 1 , 12 , 8
Application to Real Life with Considerations
Clozapine can be a valuable treatment for schizophrenia, but its use should be carefully considered due to potential side effects and individualized responses. 13 , 4 , 9 , 10 , 7 , 3 , 5 , 6 , 11 , 2 , 1 , 12 , 8
Limitations of Current Research
Further research is needed to fully understand the long-term effectiveness and safety of clozapine. 13 , 4 , 9 , 10 , 7 , 3 , 5 , 6 , 11 , 2 , 1 , 12 , 8
Future Research Directions
Continued research is necessary to fully understand the long-term effects and safety of clozapine. 13 , 4 , 9 , 10 , 7 , 3 , 5 , 6 , 11 , 2 , 1 , 12 , 8
Conclusion
Clozapine is a potentially effective treatment option for schizophrenia, particularly for those resistant to other antipsychotics. However, its use should be carefully considered due to the possibility of serious side effects, and individuals should closely monitor their response to the medication. 13 , 4 , 9 , 10 , 7 , 3 , 5 , 6 , 11 , 2 , 1 , 12 , 8
Benefit Keywords
Risk Keywords
Article Type
Author: EssockS M, HargreavesW A, CovellN H, GoetheJ
Language : English
Author: FreudenreichO, WeinerR D, McEvoyJ P
Language : English
Author: RosenheckR, CramerJ, XuW, ThomasJ, HendersonW, FrismanL, FyeC, CharneyD
Language : English
Author: BuchananR W, BreierA, KirkpatrickB, BallP, CarpenterW T
Language : English
Author: CitromeL, VolavkaJ, CzoborP, SheitmanB, LindenmayerJ P, McEvoyJ, CooperT B, ChakosM, LiebermanJ A
Language : English
Author: de LeonJose, DiazFrancisco J, JosiassenRichard C, CooperThomas B, SimpsonGeorge M
Language : English
Author: HarveyPhilip D, SacchettiEmilio, GalluzzoAlessandro, RomeoFabio, GoriniBarbara, BilderRobert M, LoebelAntony D
Language : English
Immunomodulatory effects of clozapine and their clinical implications: what have we learned so far?
Author: RøgeRasmus, MøllerBjarne K, AndersenChristian R, CorrellChristoph U, NielsenJimmi
Language : English
Author: NakajimaShinichiro, TakeuchiHiroyoshi, FervahaGagan, PlitmanEric, ChungJun Ku, CaravaggioFernando, IwataYusuke, MihashiYukiko, GerretsenPhilip, RemingtonGary, MulsantBenoit, Graff-GuerreroAriel
Language : English
Author: GarciaGiovana J, ChagasMarcos H, SilvaCarlos H, Machado-de-SousaJoão P, CrippaJosé A, HallakJaime E
Language : English
Author: PolcwiartekChristoffer, NielsenJimmi
Language : English
Author: SamaraMyrto T, DoldMarkus, GianatsiMyrsini, NikolakopoulouAdriani, HelferBartosz, SalantiGeorgia, LeuchtStefan
Language : English
Author: RossellSusan L, FrancisPaul S, GalletlyCherrie, HarrisAnthony, SiskindDan, BerkMichael, BozaogluKiymet, DarkFrances, DeanOlivia, LiuDennis, MeyerDenny, NeillErica, PhillipouAndrea, SarrisJerome, CastleDavid J
Language : English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.